MK-677 60mg — Vial Spec, Reconstitution Math & COA

Overview and Purpose of the 60mg MK-677 Vial Specification

A 60mg vial specification of MK-677 (Ibutamoren) represents a bulk analytical quantity formulated primarily for high-density, multi-subject laboratory research. Investigators working with large animal cohorts or executing repetitive assay series frequently utilize larger mass vials to maintain batch consistency across extended observational timelines.

MK-677 is a non-peptidic, orally active growth hormone secretagogue that acts as a potent selective agonist of the ghrelin receptor (GHS-R1a). In preclinical models, this small molecule is evaluated for its capacity to stimulate endogenous growth hormone (GH) secretion and subsequently elevate circulating insulin-like growth factor 1 (IGF-1) levels without significantly disrupting baseline cortisol or thyroid hormone dynamics.

Please note that while high-mass bulk vials like 60mg are frequently requested for multi-week rodent trials, PX1 Research evaluates catalog options based on strict stability and storage standards. For single-subject or discrete dosing designs, investigators may review alternate preparations, including MK-677 Capsules 12.5mg or standard lyophilized options across our catalog of all research peptides. Regardless of format, all compounds distributed are strictly intended for laboratory in vitro and animal research applications.

Molecular Profile and Preclinical Mechanism of Action

MK-677 possesses the chemical formula C27H36N4O5S and a molecular weight of 528.67 g/mol. Unlike classical peptide secretagogues, its non-peptidic structure renders it resilient to rapid enzymatic degradation by peptidases. Preclinical studies suggest that upon binding to GHS-R1a receptors in the anterior pituitary and hypothalamus, MK-677 mimics the signal transduction pathways normally triggered by endogenous ghrelin.

In vitro data indicate that activation of the GHS-R1a pathway leads to an intracellular influx of calcium ions via phosphoinositide-specific phospholipase C signaling, facilitating the pulsatile release of somatotropes. Animal models demonstrate sustained elevation of systemic IGF-1 and GH axis activity over 24-hour periods following single-dose oral or parenteral administration, making it a critical control compound in metabolic and nitrogen-retention research.

For additional foundational literature on growth axis signaling and receptor dynamics, researchers can reference the comprehensive documentation available in our central research library.

Volumetric Reconstitution Math for a 60mg Mass Vial

Achieving exact target concentrations requires precise volumetric calculation when reconstituting a 60mg solid mass. Depending on the assay protocol, investigators may select bacteriostatic water, sterile saline, or specialized solvent mixtures like PEG-400 or DMSO depending on whether the compound is prepared for aqueous parenteral research or oral gavage models.

To calculate working concentration (C), divide the total mass (60 mg) by the total diluent volume (V in mL). Researchers utilizing our digital reconstitution calculator can verify the following standard laboratory dilutions:

• Reconstitution with 1.0 mL Diluent: Yields a final concentration of 60.0 mg/mL (60 µg/µL). This high concentration is ideal for low-volume micro-injections or concentrated stock storage. • Reconstitution with 2.0 mL Diluent: Yields a final concentration of 30.0 mg/mL (30 µg/µL). This balanced concentration minimizes measurement error when handling medium-sized animal test subjects. • Reconstitution with 3.0 mL Diluent: Yields a final concentration of 20.0 mg/mL (20 µg/µL). Highly suitable for serial dilutions and multi-well plate dispensing in cellular assay setups.

Aliquot Planning and Longitudinal Trial Administration

When managing a high-mass 60mg vial over prolonged experimental windows, repeated freeze-thaw cycles or frequent container opening can compromise compound purity and introduce microbial contamination. Establishing a structured aliquoting protocol immediately after initial dissolution is essential.

For longitudinal animal studies spanning several weeks, primary stocks should be aliquoted into single-use microcentrifuge tubes under sterile laminar flow hoods. A typical aliquot schedule might divide a 3.0 mL reconstituted solution (20 mg/mL) into six 0.5 mL vials (10 mg per tube). Individual aliquots are then stored at sub-zero temperatures and thawed sequentially as testing cohorts progress.

High-throughput screening facilities requiring continuous volume provisioning may establish specialized institutional procurement arrangements through our wholesale lab account portal to maintain standardized batch control across large research programs.

Storage Conditions, Temperature Stability, and Handling

The physical stability of MK-677 depends on environmental exposure, light isolation, and thermal control. In its raw, unconstituted powder or crystalline state, MK-677 should be stored at -20°C in a desiccated, dark environment to prevent hygroscopic degradation and oxidation.

Once dissolved in solution, aqueous or organic stock preparations demonstrate varying stability profiles depending on temperature:

• Lyophilized / Powder Form: Stable at -20°C for up to 24 months; stable at 2–8°C for short-term handling up to 90 days. • Reconstituted Liquid Stock (2–8°C): Stable for up to 30 days when protected from direct UV radiation and sealed in airtight inert vials. • Frozen Liquid Aliquots (-20°C to -80°C): Stable for 6 to 12 months. Repeated thermal cycling must be strictly avoided to prevent chemical precipitation or structural breakdown.

Analytical Certificate of Analysis (COA) and Purity Standards

Every production lot of MK-677 supplied by PX1 Research undergoes rigorous verification protocols to ensure analytical consistency and low endotoxin levels. High-mass vials require stringent quality assurance due to the high volume of research data dependent on a single batch.

Researchers can inspect and download the lot-matched testing reports directly via our COA verification portal. Quality verification criteria include:

• High-Performance Liquid Chromatography (HPLC): Confirms chemical purity exceeding 99.0%, ensuring the absence of unreacted intermediates or degradation byproducts. • Mass Spectrometry (MS): Verifies exact molecular mass (528.67 g/mol) and identity validation. • Endotoxin Assay (LAL Test): Verifies compliance with strict threshold limits (<0.01 EU/mg) for cellular and animal model compatibility.

Comparative Analysis: MK-677 vs. Peptide Secretagogues

Researchers evaluating secretagogue mechanisms frequently compare MK-677 against classical peptide-based GH secretagogues. While MK-677 targets the GHS-R1a ghrelin receptor through non-peptidic oral/parenteral pathways, traditional peptides operate through distinct receptor pathways or shorter half-life profiles.

For instance, Ipamorelin acts as a highly selective peptide agonist of the ghrelin receptor with a brief half-life (~2 hours), requiring frequent pulse administration in preclinical protocols. Conversely, CJC-1295 No DAC targets the growth hormone-releasing hormone (GHRH) receptor, providing a synergistic mechanism when studied in tandem with GHS-R1a agonists. Similarly, Sermorelin offers a truncated GHRH fragment model for studying acute pituitary somatotrope stimulation. MK-677 is distinguished from these compounds by its long half-life (~24 hours) and resistance to peptidase cleavage.

Selecting Optimal Vial Mass Formats for Experimental Protocols

Choosing between a 60mg bulk vial and smaller mass formats (e.g., 10mg or 20mg) depends primarily on the trial design, sample size, and duration of the study. A 60mg vial offers significant logistical efficiency for continuous, multi-subject rodent trials, eliminating lot-to-lot variance across extended dosing schedules.

However, if an experimental design involves short-duration pilot studies, single-cell culture assays, or infrequent testing intervals, smaller vial sizes or pre-measured solid forms like MK-677 Capsules 12.5mg may reduce reagent waste and eliminate concerns regarding long-term solution stability in storage.